Scholar Rock Holding (SRRK) Share-based Compensation (2017 - 2026)
Scholar Rock Holding's quarterly Share-based Compensation came in at $18.2 million in Q1 2026, up 36.02% year-on-year from $13.4 million in Q1 2025, and down 6.06% quarter-over-quarter from $19.4 million in Q4 2025.
Scholar Rock Holding has reported Share-based Compensation for 10 years, with the latest figure at $18.2 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 36.02% year-over-year to $18.2 million; the trailing twelve-month figure through Mar 2026 stood at $80.4 million (up 92.07% YoY), and the FY2025 full-year result was $75.6 million, up 106.4% from the prior year.
- Share-based Compensation for Q1 2026 stood at $18.2 million, down from $19.4 million in the prior quarter.
- The five-year high for Share-based Compensation was $24.4 million in Q2 2025, with the low at $6.2 million in Q4 2022.
- Average Share-based Compensation over 5 years is $10.9 million, with a median of $8.2 million recorded in 2024.
- Year-over-year, Share-based Compensation retreated 9.64% in 2023 and soared 162.41% in 2025.
- Tracing SRRK's Share-based Compensation over 5 years: stood at $6.2 million in 2022, then advanced by 12.75% to $7.0 million in 2023, then soared by 36.7% to $9.5 million in 2024, then surged by 104.41% to $19.4 million in 2025, then decreased by 6.06% to $18.2 million in 2026.
- The last three Share-based Compensation figures came in at $18.2 million (Q1 2026), $19.4 million (Q4 2025), and $18.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 18.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.25 Mn |
| Mar 31, 2026 | 18.25 Mn |
| Dec 31, 2025 | 19.42 Mn |
| Dec 31, 2025 | 19.42 Mn |
| Sep 30, 2025 | 18.33 Mn |
| Sep 30, 2025 | 18.33 Mn |
| Jun 30, 2025 | 24.43 Mn |
| Jun 30, 2025 | 24.43 Mn |
| Mar 31, 2025 | 13.41 Mn |
| Mar 31, 2025 | 13.41 Mn |
| Dec 31, 2024 | 9.50 Mn |
| Dec 31, 2024 | 9.50 Mn |
| Sep 30, 2024 | 9.65 Mn |
| Sep 30, 2024 | 9.65 Mn |
| Jun 30, 2024 | 9.31 Mn |
| Jun 30, 2024 | 9.31 Mn |
| Mar 31, 2024 | 8.16 Mn |
| Mar 31, 2024 | 8.16 Mn |
| Dec 31, 2023 | 6.95 Mn |
| Dec 31, 2023 | 6.95 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 6.82 Mn |
| Jun 30, 2023 | 6.82 Mn |
| Mar 31, 2023 | 6.17 Mn |
| Mar 31, 2023 | 6.17 Mn |
| Dec 31, 2022 | 6.17 Mn |
| Dec 31, 2022 | 6.17 Mn |
| Sep 30, 2022 | 7.92 Mn |
| Sep 30, 2022 | 7.92 Mn |
| Jun 30, 2022 | 6.79 Mn |
| Jun 30, 2022 | 6.79 Mn |
| Mar 31, 2022 | 6.83 Mn |
| Mar 31, 2022 | 6.83 Mn |
| Dec 31, 2021 | 6.10 Mn |
| Dec 31, 2021 | 6.10 Mn |
| Sep 30, 2021 | 6.15 Mn |
| Sep 30, 2021 | 6.15 Mn |
| Jun 30, 2021 | 6.23 Mn |
| Jun 30, 2021 | 6.23 Mn |
| Mar 31, 2021 | 4.67 Mn |
| Mar 31, 2021 | 4.67 Mn |
| Dec 31, 2020 | 2.53 Mn |
| Dec 31, 2020 | 2.53 Mn |
| Sep 30, 2020 | 4.04 Mn |
| Sep 30, 2020 | 4.04 Mn |
| Jun 30, 2020 | 2.40 Mn |
| Jun 30, 2020 | 2.40 Mn |
| Mar 31, 2020 | 2.21 Mn |
| Mar 31, 2020 | 2.21 Mn |
| Dec 31, 2019 | 1.85 Mn |
| Dec 31, 2019 | 1.85 Mn |
| Sep 30, 2019 | 2.69 Mn |
| Sep 30, 2019 | 2.69 Mn |
| Jun 30, 2019 | 1.81 Mn |
| Jun 30, 2019 | 1.81 Mn |
| Mar 31, 2019 | 1.62 Mn |
| Mar 31, 2019 | 1.62 Mn |
| Dec 31, 2018 | 2.15 Mn |
| Dec 31, 2018 | 2.15 Mn |
| Sep 30, 2018 | 1.49 Mn |
| Sep 30, 2018 | 1.49 Mn |
| Jun 30, 2018 | 1.09 Mn |
| Jun 30, 2018 | 1.09 Mn |
| Mar 31, 2018 | 482,000.00 |
| Mar 31, 2018 | 482,000.00 |
| Dec 31, 2017 | 793,000.00 |
| Dec 31, 2017 | 793,000.00 |
| Sep 30, 2017 | 201,000.00 |
| Sep 30, 2017 | 201,000.00 |
| Jun 30, 2017 | 232,000.00 |
| Jun 30, 2017 | 232,000.00 |